Truist lowered the firm’s price target on Lineage (LINE) to $40 from $53 and keeps a Buy rating on the shares. The firm, which is lowering its earnings estimates, largely due to more conservative ...
Morgan Stanley lowered the firm’s price target on Lineage (LINE) to $39 from $46 and keeps an Equal Weight rating on the shares. There is ...
Lineage (NASDAQ:LINE – Get Free Report) had its price target lowered by research analysts at Piper Sandler from $75.00 to $60.00 in a research report issued on Monday,Benzinga reports. The brokerage ...